American International Group, Inc. Aveo Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$6.21 - $7.45 $79,022 - $94,801	-12,725 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$5.97 - $15.28 $197 - $504	33 Added 0.26%	12,725 $93,000
Q4 2020 Feb 12, 2021	SELL	$5.08 - $6.68 $1,849 - $2,431	-364 Reduced 2.79%	12,692 $73,000
Q3 2020 Nov 04, 2020	BUY	$4.16 - $6.26 $19,701 - $29,647	4,736 Added 56.92%	13,056 $78,000
Q2 2020 Aug 12, 2020	BUY	$3.47 - $9.99 $28,870 - $83,116	8,320 New	8,320 $43,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.